Literature DB >> 18408464

Cholangiocarcinoma: lessons from Thailand.

Banchob Sripa1, Chawalit Pairojkul.   

Abstract

PURPOSE OF REVIEW: To present the background of liver fluke-associated cholangiocarcinoma in Thailand focusing on recent epidemiological data and pathogenesis of this bile duct cancer. RECENT
FINDINGS: More systematic tumor registration in Thailand nowadays uncovers new high-incidence areas that are confined to not only the northeastern part but also some provinces in northern Thailand. The link between the liver fluke, Opisthorchis viverrini, and cholangiocarcinoma, particularly in terms of cellular and molecular pathogenesis, is further elucidated.
SUMMARY: Thailand is still the country with the highest incidence of cholangiocarcinoma in the world. Liver fluke induces chronic inflammation leading to oxidative DNA damage of the infected biliary epithelium and malignant transformation. Eradication of the fluke and identification of high-risk populations are urgently needed.

Entities:  

Mesh:

Year:  2008        PMID: 18408464      PMCID: PMC4130346          DOI: 10.1097/MOG.0b013e3282fbf9b3

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  35 in total

1.  Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.

Authors:  H Suzuki; S Isaji; C Pairojkul; T Uttaravichien
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

Review 2.  Clinical manifestation of opisthorchiasis and treatment.

Authors:  Eimorn Mairiang; Pisaln Mairiang
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

Review 3.  Opisthorchiasis control in Thailand.

Authors:  P Jongsuksuntigul; T Imsomboon
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

Review 4.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 5.  Precancerous lesions of intrahepatic cholangiocarcinoma.

Authors:  T Shimonishi; M Sasaki; Y Nakanuma
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

6.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.

Authors:  Yasser H Shaib; Hashem B El-Serag; Ajay K Nooka; Melanie Thomas; Thomas D Brown; Yehuda Z Patt; Manal M Hassan
Journal:  Am J Gastroenterol       Date:  2007-02-23       Impact factor: 10.864

7.  Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.

Authors:  M Kobayashi; K Ikeda; S Saitoh; F Suzuki; A Tsubota; Y Suzuki; Y Arase; N Murashima; K Chayama; H Kumada
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

8.  Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.

Authors:  Peter Jepsen; Hendrik Vilstrup; Robert E Tarone; Søren Friis; Henrik Toft Sørensen
Journal:  J Natl Cancer Inst       Date:  2007-06-06       Impact factor: 13.506

9.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

Review 10.  Pathobiology of opisthorchiasis: an update.

Authors:  Banchob Sripa
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

View more
  168 in total

1.  Exceptionally high prevalence of infection of Bithynia siamensis goniomphalos with Opisthorchis viverrini cercariae in different wetlands in Thailand and Lao PDR.

Authors:  Nadda Kiatsopit; Paiboon Sithithaworn; Weerachai Saijuntha; Thidarut Boonmars; Smarn Tesana; Jiraporn Sithithaworn; Trevor N Petney; Ross H Andrews
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.

Authors:  Pakkayanee Sudsarn; Thidarut Boonmars; Wipaporn Ruangjirachuporn; Nisana Namwat; Watcharin Loilome; Pranee Sriraj; Ratchadawan Aukkanimart; Wonkchalee Nadchanan; Songsri Jiraporn
Journal:  Pathol Oncol Res       Date:  2015-08-16       Impact factor: 3.201

3.  Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells.

Authors:  Wongwarut Boonyanugomol; Chariya Chomvarin; Seung-Chul Baik; Jea-Young Song; Chariya Hahnvajanawong; Kyung-Mi Kim; Myung-Je Cho; Woo-Kon Lee; Hyung-Lyun Kang; Kwang-Ho Rhee; Banchob Sripa
Journal:  Dig Dis Sci       Date:  2010-12-22       Impact factor: 3.199

4.  Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Sasithorn Kaewkes; Porntip Laummaunwai; Somchai Pinlaor; Watchalin Loilome; Puangrat Yongvanit; Zhiliang Wu; Anucha Puapairoj; Vajarabhongsa Bhudhisawasdi
Journal:  Pathol Oncol Res       Date:  2011-07-13       Impact factor: 3.201

5.  Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination.

Authors:  Julie K Heimbach; William Sanchez; Charles B Rosen; Gregory J Gores
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

6.  Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.

Authors:  Kawin Leelawat; Siriluck Narong; Jerasak Wannaprasert; Thawee Ratanashu-ek
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

7.  Bone metastasis from cholangiocarcinoma mimicking osteosarcoma: A case report and review literature.

Authors:  Prin Chindaprasirt; Julaluck Promsorn; Piti Ungareewittaya; Nattaphon Twinprai; Jarin Chindaprasirt
Journal:  Mol Clin Oncol       Date:  2018-09-17

Review 8.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

9.  Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.

Authors:  Apaporn Menakongka; Tuangporn Suthiphongchai
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 10.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.